This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting and losses recognized for other than temporary impairments (OTTI) of the subject investments.

+ References+ Details

Balance held at close of period in number of shares.

+ References+ Details

- Definition

Number of share options (or share units) exercised during the current period.

+ References+ Details

Note 1 - Principles of Consolidation and Basis of Presentation (Details) (USD $)	3 Months Ended		6 Months Ended	3 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012 Common Stock [Member]	Mar. 31, 2013 iBio, Inc. [Member]	Dec. 31, 2013 iBio, Inc. [Member]	Aug. 31, 2008 iBio, Inc. [Member]
Note 1 - Principles of Consolidation and Basis of Presentation (Details) [Line Items]
Equity Method Investment, Ownership Percentage							6.00%
Investment Owned, Balance, Shares (in Shares)							1,266,706
Gain (Loss) on Investments (in Dollars)					$ (139,000)
Equity Method Investment, Quoted Market Value (in Dollars)						$ 400,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)	73,012	219,581	37,017	634,500